Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Elucidating the biochemistry of wall teichoic acid length sensing by the poly(glycerol phosphate)polymerase, TagF, in Bacillus subtilis 168
EF 2011-12
Résumé
In the past decades we have witnessed an alarming rise of antibiotic resistant bacteria, coupled with a complete absence of novel acting antibiotic compounds to meet this challenge. Indeed, most 'new' antibiotics in the clinic today are structural derivatives of those developed prior to the sixties. It has thus become evident that new approaches to antibiotic drug development must be taken. To this, researchers have been trying to identify new targets in bacteria to which no pre-existing resistance mechanisms exist to act as models for drug design. Our group has highlighted the negatively charged bacterial cell wall polymers, wall teichoic acid, as a particularly attractive druggable target, as it is an abundant, vital component for the survivorship and functionality of Gram-positive bacteria, and a key determinant to pathogenesis in the clinically prevalent pathogen Staphlococcus aureus. A key feature of course to this new antibiotic development strategy is that one must first understand the biological complexity of the desired target. Our research team has made great strides in demystifying the steps involved in building bacterial wall teichoic acids, however still much remains to be elucidated before this pathway can be used as a model for novel antibiotic drug discovery. In this project we plan to generate a physiologically relevant model system under which the later stages of wall teichoic acid biosynthesis can be studied. With this in place, we can obtain a meticulous understanding of the process and hone-in on precise areas of interest for antibiotic development. It is our hope that through these studies we can identify novel acting antibiotics to thwart pathogenesis of the clinically troublesome pathogen S. aureus and provide a new arsenal of antibiotics to combat resistance found in numerous Gram-positive bacteria.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
253342
Name
Gale Robert T
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Elucidating the biochemistry of wall teichoic acid length sensing by the poly(glycerol phosphate)polymerase, TagF, in Bacillus subtilis 168
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antibiotic; Bacterial Cell Wall; Bacterial Genetics; Enzymology; Infection; Polymerase; Wall Teichoic Acid
Abstract
In the past decades we have witnessed an alarming rise of antibiotic resistant bacteria, coupled with a complete absence of novel acting antibiotic compounds to meet this challenge. Indeed, most 'new' antibiotics in the clinic today are structural derivatives of those developed prior to the sixties. It has thus become evident that new approaches to antibiotic drug development must be taken. To this, researchers have been trying to identify new targets in bacteria to which no pre-existing resistance mechanisms exist to act as models for drug design. Our group has highlighted the negatively charged bacterial cell wall polymers, wall teichoic acid, as a particularly attractive druggable target, as it is an abundant, vital component for the survivorship and functionality of Gram-positive bacteria, and a key determinant to pathogenesis in the clinically prevalent pathogen Staphlococcus aureus. A key feature of course to this new antibiotic development strategy is that one must first understand the biological complexity of the desired target. Our research team has made great strides in demystifying the steps involved in building bacterial wall teichoic acids, however still much remains to be elucidated before this pathway can be used as a model for novel antibiotic drug discovery. In this project we plan to generate a physiologically relevant model system under which the later stages of wall teichoic acid biosynthesis can be studied. With this in place, we can obtain a meticulous understanding of the process and hone-in on precise areas of interest for antibiotic development. It is our hope that through these studies we can identify novel acting antibiotics to thwart pathogenesis of the clinically troublesome pathogen S. aureus and provide a new arsenal of antibiotics to combat resistance found in numerous Gram-positive bacteria.
Competitiondate
201202
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gale, Robert T
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~